Insmed (INSM) Misses Q1 EPS by 3c

Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.74), $0.03 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $34.8 million.

For earnings history and earnings-related data on Insmed (INSM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Arena Group to rename as Paradium.AI, ticker changing to PAAI
• Beike (BEKE) PT Raised to $23 at Morgan Stanley